We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Artificial Minitransposon Used to Create Protein Mutation Expression Library

By LabMedica International staff writers
Posted on 20 Feb 2012
An efficient new method for producing mutated-protein expression libraries provides unique benefits for protein structure-function studies and for protein engineering.

The minitransposon was specifically designed and used, by random insertion via the MuA transposase enzyme, to create a gene library for expressing a set of protein mutants that provides distinct protein sequence diversity over existing methods. More...


Libraries expressing multiple mutants of a given protein are particularly useful for studying protein mechanisms and the adaptation of proteins during molecular evolution, as well as for designing proteins (such as biosensors and molecular switches) with novel functions in synthetic biology, including potential drug therapy enzymes.

One type of library in use is made up of "circularly permuted" protein mutants, proteins that have been mutated by connecting the two ends (the N- and C-termini) and later breaking elsewhere, often also having altered part(s) in between.

The new method, called PERMutation Using Transposase Engineering (PERMUTE), for making this type of library was developed by senior undergraduate student Manan Mehta and mentor Jonathan Silberg, assistant professor, at Rice University's Department of Biochemistry and Cell Biology (Houston, TX, USA), with assistance from research technician and coauthor Shirley Liu.

"Creating such a library has traditionally required painstaking processes," said Prof. Silberg. "Existing methods for rearranging the bits of information in a protein are slow and arduous to use," he said. "In addition, they are nonideal because they simultaneously create multiple types of mutations, the desired rearrangements, and undesired deletions of important amino acids.”

Prof. Silberg further explained, "With our method, you only generate mutants with rearranged sequences, and you don't need to be an expert in biomolecular engineering. All you need is the DNA that encodes your gene of interest, the artificial minitransposon we engineered and an enzyme. […] It's a way of making, with great control, all of the diversity of this type of mutation that could exist in a protein."

In this particular study, published online ahead of print on February 7, 2012, in the journal Nucleic Acids Research, a library was created where the enzyme adenylate kinase was mutated. The library of mutant proteins was then mined for variants that retained catalytic functional by introducing them into Escherichia coli bacteria then screening and selecting for adenylate kinase activity. Out of about 220 sequenced mutants (about half of which were active), 15 unique sequence variants were identified.

The work was supported by the National Aeronautics and Space Administration (NASA; USA) and the Robert A. Welch Foundation (The Welch Foundation; Houston, TX, USA).

Related Links:

Rice University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.